North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Forecast to 2030
North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Forecast to 2030 – Regional Analysis – By Product (Instruments, Consumables, Accessories, and Software), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Infectious Disease Diagnostic, and Others), and End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Automation and Digitalization of Fish Imaging Technique Fuel North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market
An automated FISH enumeration system facilitates the automatic detection and counting of FISH signals generated by interphase nuclei in formalin-fixed, paraffin-embedded human tissue specimens. This system consists of standard hardware components, including an automated scanning microscope and an image analysis system, and software platforms with FISH assay-specific applications (apps). Automated FISH enumeration systems are designed to be used with FISH assays for IVD purposes to identify, count, and classify cells based on their size, shape, and colour. Adopting automated technologies may result in reduced hands-on time compared to manual FISH test enumeration systems. FISH is a gold standard method for diagnostics owing to the ease of use and the ability to provide same-day results after sample collection. The automation of FISH imaging with reduced probe volumes and less hands-on time is likely to further fuel the application of FISH testing in clinical and research laboratories soon, ultimately driving better patient outcomes. Integrating FISH imaging with digital pathology platforms would facilitate remote collaboration among experts and open avenues for telepathology. Advancements in imaging technologies are likely to result in higher-resolution imaging, improved fluorophores, and sophisticated image analysis algorithms, fostering precise genetic visualization and enhancing FISH imaging tools. In the future, FISH technology is anticipated to play an important role in personalized medicine, aiding in tailoring treatment strategies based on individual genetic profiles. The integration of AI and machine learning, offering insights from vast datasets and predicting disease outcomes, would further amplify the diagnostic potential of FISH imaging. Thus, automation and digitalization are likely to emerge as significant trends in the fluorescence in situ hybridization (FISH) imaging systems market.
North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Overview
The North American North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is segmented into the US, Canada, and Mexico. An increase in the prevalence of target disorders propels the need for clinical urgency alternatives, which drives the market growth in the region. The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics and the rising prevalence of genetic disorders and cancer fuel the adoption of fluorescence in-situ hybridization (FISH) imaging systems. As per data published by the American Cancer Society in 2022, in US there are around 1.9 million new cancer cases diagnosed and 609,360 cancer deaths. These systems offer high-resolution imaging of genetic material, enabling researchers and clinicians to detect chromosomal abnormalities and gene mutations with greater accuracy. Furthermore, the increasing focus on personalized medicine and targeted therapies has led to an upsurge in research activities involving genetic analysis, bolstering the demand for FISH imaging systems. The ability of these systems to provide detailed spatial information on gene sequences directly within cells has proven invaluable in both research and clinical applications. The popularity of technological advancements in FISH imaging systems, such as improved automation, higher throughput, and enhanced image analysis software, has also increased in recent years. As a result, laboratories and medical institutions are better equipped to handle larger volumes of samples and generate precise results efficiently.
North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Revenue and Forecast to 2030 (US$ Million)
North America Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Segmentation
The North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into product, application, end users and country.
Based on product, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
In terms of application, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
Based on end user, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest share of the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
By country, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented int o the US, Canada, and Mexico. The US dominated the North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022.
Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, and Applied Spectral Imaging are some of the leading companies operating in the North America fluorescence in-situ hybridization (FISH) imaging systems market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research, the North America fluorescence in-situ hybridization (FISH) imaging systems market was valued at US$ 507.0 million in 2022 and is expected to reach US$ 885.4 million by 2030, registering a CAGR of 7.2% from 2022 to 2030. Rising prevalence of target disorders and increasing R&D investments in in-vitro diagnostics attributed to the North America fluorescence in-situ hybridization (FISH) imaging systems market expansion.
FISH is a powerful molecular cytogenetic technique that allows the visualization and localization of specific DNA sequences within cells or tissues. This technology has revolutionized the field of genetics and diagnostics, providing researchers and clinicians with valuable insights into genetic abnormalities, chromosomal rearrangements, and various diseases. The increasing prevalence of target disorders such as genetic syndromes and cancer, and other genetic anomalies drives the demand for FISH imaging systems. According to the National Library of Medicine, the US is expected to record 1.96 new cancer cases and 609,820 cancer deaths in 2023. The demand for accurate and reliable diagnostic tools surges with the continued rise in the prevalence of these target disorders. FISH imaging systems provide high-resolution images to aid the detection of subtle genetic changes, enabling early disease diagnosis and personalized treatment approaches. These disorders often involve genetic mutations or variations that can be accurately identified and characterized using FISH imaging systems. The ability to precisely map the location of specific genes or DNA sequences within cells has proven crucial for understanding disease mechanisms, developing targeted therapies, and making informed clinical decisions. A prominent advantage of FISH lies in its ability to work with various sample types, including formalin-fixed paraffin-embedded tissues, cytological preparations, and fresh tissues. This versatility has made FISH an essential tool in both research and clinical settings, allowing the identification of genetic markers associated with diseases such as leukemia, lymphoma, solid tumors, and congenital disorders.
On the contrary, high cost of FISH imaging systems and procedures hampers the North America fluorescence in-situ hybridization (FISH) imaging systems market.
Based on product, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables held 54.3% share of North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022, amassing US$ 249.6 million. It is projected to garner US$ 442.3 million by 2030 to expand at 7.4% CAGR during 2022–2030.
In terms of application, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held 48.6% share of North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022, amassing US$ 246.4 million. It is projected to garner US$ 441.0 million by 2030 to expand at 7.5% CAGR during 2022–2030.
Based on end users, the North America fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held 78.2% share of North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022, amassing US$ 396.5 million. It is projected to garner US$ 695.9 million by 2030 to expand at 7.3% CAGR during 2022–2030.
By country, the North America fluorescence in-situ hybridization (FISH) imaging systems market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 82.8% share of North America fluorescence in-situ hybridization (FISH) imaging systems market in 2022. It was assessed at US$ 419.74 million in 2022 and is likely to hit US$ 733.71 million by 2030, exhibiting a CAGR of 7.2% during 2022–2030.
Key players operating the North America fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, and Applied Spectral Imaging, among others.
Bio-View Ltd in Apr-2023, Partnership ANGLE Plc, a global leader in liquid biopsy, entered into a collaboration with BioView Ltd to develop a liquid biopsy circulating tumor cell (CTC) HER2 assay for breast cancer using ANGLE’s FDA-cleared Parsortix PC1 Clinical System to harvest CTCs and BioView’s automated microscopy systems and software to detect and assess HER2 expression and/or gene amplification in CTCs. Thermo Fisher Scientific Inc in Jan-2023, Mergers and Acquisitions Thermo Fisher Scientific Inc, the world leader in serving science, had completed its acquisition of The Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by Nordic Capital in an all-cash transaction valued at GBP 2.3 billion, or US$ 2.8 billion at current exchange rates. The Binding Site adds pioneering innovation in diagnosis and monitoring for multiple myeloma to the existing specialty diagnostics portfolio. Early detection and informed treatment decisions can substantially impact patient outcomes.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America fluorescence in-situ hybridization (FISH) imaging systems market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America fluorescence in-situ hybridization (FISH) imaging systems market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Rising Prevalence of Target Disorders
4.1.2 Increasing R&D Investments in In-Vitro Diagnostics
4.2 Key Market Restraints:
4.2.1 High Cost of FISH Imaging Systems and Procedures
4.3 Key Market Opportunities:
4.3.1 Technological Advancements in Fluorescence In Situ Hybridization Imaging
4.4 Future Trends:
4.4.1 Automation and Digitalization of FISH Imaging Technique
4.5 Impact Analysis:
5. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – North America Market Analysis
5.1 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 – 2030
6. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Instruments
6.3.1 Overview
6.3.2 Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Consumables
6.4.1 Overview
6.4.2 Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Accessories
6.5.1 Overview
6.5.2 Accessories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Software
6.6.1 Overview
6.6.2 Software: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer Diagnosis
7.3.1 Overview
7.3.2 Cancer Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Genetic Disease Diagnosis
7.4.1 Overview
7.4.2 Genetic Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Infectious Disease Diagnosis
7.5.1 Overview
7.5.2 Infectious Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Diagnostic Laboratories
8.3.1 Overview
8.3.2 Diagnostic Laboratories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Contract Research Organization
8.4.1 Overview
8.4.2 Contract Research Organization: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Pharmaceutical And Biotechnological Companies
8.5.1 Overview
8.5.2 Pharmaceutical and Biotechnological Companies: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Country Analysis
9.1 North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
9.1.1 Overview
9.1.2 North America , by Country, 2022 & 2030 (%)
9.1.2.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.1.1 Overview
9.1.2.1.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.1.3 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
9.1.2.1.3.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
9.1.2.1.3.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
9.1.2.1.4 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
9.1.2.1.5 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
9.1.2.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.1 Overview
9.1.2.2.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.3 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
9.1.2.2.3.1 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
9.1.2.2.3.2 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
9.1.2.2.4 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
9.1.2.2.5 Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
9.1.2.3 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.3.1 Overview
9.1.2.3.2 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.3.3 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020–2030 (US$ Million)
9.1.2.3.3.1 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020–2030 (US$ Million)
9.1.2.3.3.2 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020–2030 (US$ Million)
9.1.2.3.4 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020–2030 (US$ Million)
9.1.2.3.5 Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020–2030 (US$ Million)
10. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 TissueGnostics GmbH
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Agilent Technologies Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 BioGenex Laboratories Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Leica Biosystems Nussloch GmbH
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 MetaSystems Probes GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Bio-View Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Thermo Fisher Scientific Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Applied Spectral Imaging
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 PerkinElmer Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Euroclone SpA
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation
Table 2. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 3. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 4. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 8. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Recent Inorganic Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
Table 18. Recent Organic Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
Table 19. Glossary of Terms, North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
LIST OF FIGURES
Figure 1. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation, By Country
Figure 2. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 – 2030
Figure 5. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Instruments: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Consumables: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Accessories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Cancer Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infectious Disease Diagnosis: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16. Diagnostic Laboratories: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Contract Research Organization: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Pharmaceutical and Biotechnological Companies: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Key Country – Revenue (2022) (US$ Million)
Figure 21. North America , by Country, 2022 & 2030 (%)
Figure 22. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Canada Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Mexico Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Growth Strategies in the North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
The List of Companies – North America Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
o Euroclone SpA
o TissueGnostics GmbH
o Agilent Technologies Inc
o Abnova Taiwan Corp
o BioGenex Laboratories Inc
o Leica Biosystems Nussloch GmbH
o MetaSystems Probes GmbH
o Bio-View Ltd
o Thermo Fisher Scientific Inc
o Applied Spectral Imaging
You must be logged in to post a review.
Reviews
There are no reviews yet.